Enlarge image
Corona test offer in Potsdam
Photo: Soeren Stache / dpa
According to the Robert Koch Institute (RKI), the
number of known infections
in Germany has increased by
54,504
to over 32 million.
That is 5,907 fewer cases than on Tuesday a week ago, when 60,411 infections were recorded.
The
seven-day incidence
is
247.3
, down from 288.5 the Tuesday before (Monday's numbers are meaningless because of the weekend).
The RKI reports
119 more deaths
related to the corona virus (146 last Tuesday).
The known total is 147,223.
In general, this information only provides a very incomplete picture of the number of infections.
Experts have been assuming for some time that there will be a large number of cases not recorded by the RKI - mainly because by far not all infected people have a PCR test done.
Only positive PCR tests count in the statistics.
In addition, late registrations or transmission problems can lead to the distortion of individual daily values.
Here, too, comparisons of the data are only possible to a limited extent due to the test behavior, late registrations and transmission problems.
In general, the number of registered new infections and deaths varies significantly from weekday to weekday, since many federal states do not transmit them to the RKI, especially at weekends, and report their cases later in the week.
In the case of corona vaccinations, the federal government plans to start with advanced vaccines for newer virus variants at the beginning of September.
Subject to the expected EU-wide approval, around 14 million doses adapted to the BA.1 variant are to come from Biontech and Moderna in the two weeks starting September 5th.
This emerges from a letter from Health Minister Karl Lauterbach (SPD).
According to study data, they also worked significantly better against the currently predominant BA.5 variant than first-generation vaccines, the letter says.
The SPIEGEL had first reported about it.
Specifically, five million doses of the BA.1 vaccine from Biontech/Pfizer are expected in the first two weeks of September.
The manufacturer Moderna will initially deliver 1.65 million doses and in the second week 2.38 million doses of BA.1 vaccine.
The preparations are to be delivered directly to pharmaceutical wholesalers.
Service providers such as medical practices and vaccination centers should then be able to order the two vaccines for the first time on September 5th.
jok/Reuters
